Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 588,830 | 530,180 | 347,487 | 605,378 | 594,612 |
| Marketable Securities | 432,301 | 416,602 | 304,606 | 172,266 | 139,794 |
| Receivables | 264,819 | 263,865 | 240,584 | 203,623 | 199,403 |
| Inventories | 136,987 | 127,373 | 128,534 | 127,475 | 132,841 |
| TOTAL | $1,533,117 | $1,452,487 | $1,120,270 | $1,194,369 | $1,148,186 |
| Non-Current Assets | |||||
| PPE Net | 690,332 | 703,083 | 702,041 | 698,354 | 692,404 |
| Intangibles | 4,231,849 | 4,210,450 | 4,233,908 | 4,257,516 | 4,279,821 |
| Other Non-Current Assets | 293,273 | 307,275 | 320,102 | 321,095 | 300,419 |
| TOTAL | $5,215,454 | $5,220,808 | $5,256,051 | $5,276,965 | $5,272,644 |
| Total Assets | $6,748,571 | $6,673,295 | $6,376,321 | $6,471,334 | $6,420,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 249,038 | 248,923 | 298,810 | 50,000 | 50,000 |
| Accounts payable and accrued liabilities | 97,653 | 52,980 | 60,498 | 78,816 | 73,558 |
| Accrued Expenses | 313,997 | 302,540 | 265,121 | 341,683 | 309,872 |
| Other current liabilities | 35,804 | 37,103 | 33,455 | 14,823 | 12,694 |
| TOTAL | $723,662 | $668,642 | $685,109 | $514,701 | $476,513 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,814,398 | 2,812,291 | 2,558,594 | 2,811,328 | 2,823,090 |
| TOTAL | $2,814,398 | $2,812,291 | $2,558,594 | $2,811,328 | $2,823,090 |
| Total Liabilities | $3,538,060 | $3,480,933 | $3,243,703 | $3,326,029 | $3,299,603 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 185,076 | 184,770 | 184,530 | 181,531 | 180,850 |
| Common Shares | 1,852 | 1,848 | 1,839 | 1,815 | 1,809 |
| Retained earnings | -3,633,447 | -3,595,211 | -3,579,403 | -3,469,175 | -3,419,409 |
| Other shareholders' equity | 4,630 | -943 | -499 | 1,428 | -1,535 |
| TOTAL | $3,210,511 | $3,192,362 | $3,132,618 | $3,145,305 | $3,121,227 |
| Total Liabilities And Equity | $6,748,571 | $6,673,295 | $6,376,321 | $6,471,334 | $6,420,830 |